These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31864103)

  • 1. Cross-sectional analysis of adhesion in individuals with sickle cell disease using a standardized whole blood adhesion bioassay to VCAM-1.
    White J; Lancelot M; Gao X; McGraw BJ; Tabb C; Hines P
    Blood Cells Mol Dis; 2020 Mar; 81():102397. PubMed ID: 31864103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal assessment of adhesion to vascular cell adhesion molecule-1 at steady state and during vaso-occlusive crises in sickle cell disease.
    White J; Callaghan MU; Gao X; Liu K; Zaidi A; Tarasev M; Hines PC
    Br J Haematol; 2022 Feb; 196(4):1052-1058. PubMed ID: 34850378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased erythrocyte adhesion to VCAM-1 during pulsatile flow: Application of a microfluidic flow adhesion bioassay.
    White J; Lancelot M; Sarnaik S; Hines P
    Clin Hemorheol Microcirc; 2015; 60(2):201-13. PubMed ID: 24898561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
    Hines PC; Callaghan MU; Zaidi AU; Gao X; Liu K; White J; Tarasev M
    Br J Haematol; 2021 Sep; 194(6):1074-1082. PubMed ID: 34472086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow.
    White J; Krishnamoorthy S; Gupta D; Lancelot M; Moore N; Sarnaik S; Hobbs WE; Light DR; Hines P
    Br J Haematol; 2016 Sep; 174(6):970-82. PubMed ID: 27291690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative intervention for the prevention of vaso-occlusive episodes in sickle cell disease.
    Jeon WJ; Joung B; Moon JH; Hino C; Park D; Pham B; Castillo DR; Chong E; Kaur S; Grismore C; Cao H
    Hematology; 2023 Dec; 28(1):2215575. PubMed ID: 37227254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.
    Alapan Y; Kim C; Adhikari A; Gray KE; Gurkan-Cavusoglu E; Little JA; Gurkan UA
    Transl Res; 2016 Jul; 173():74-91.e8. PubMed ID: 27063958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-stranded RNA induces sickle erythrocyte adherence to endothelium: a potential role for viral infection in vaso-occlusive pain episodes in sickle cell anemia.
    Smolinski PA; Offermann MK; Eckman JR; Wick TM
    Blood; 1995 May; 85(10):2945-50. PubMed ID: 7537985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of vascular endothelial growth factor levels in sickle cell disease.
    Gürkan E; Tanriverdi K; Başlamişli F
    Ann Hematol; 2005 Feb; 84(2):71-5. PubMed ID: 15322765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
    Conran N; Fattori A; Saad ST; Costa FF
    Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
    Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
    Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion.
    Finnegan EM; Turhan A; Golan DE; Barabino GA
    Am J Hematol; 2007 Apr; 82(4):266-75. PubMed ID: 17094094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.
    Gambero S; Canalli AA; Traina F; Albuquerque DM; Saad ST; Costa FF; Conran N
    Eur J Haematol; 2007 Feb; 78(2):144-51. PubMed ID: 17313560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice.
    Perkins LA; Nyiranshuti L; Little-Ihrig L; Latoche JD; Day KE; Zhu Q; Tavakoli S; Sundd P; Novelli EM; Anderson CJ
    Blood Adv; 2020 Sep; 4(17):4102-4112. PubMed ID: 32882004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD.
    Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K
    Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet agents for preventing vaso-occlusive events in people with sickle cell disease: a systematic review.
    Martí-Carvajal A; Abd El Aziz MA; Martí-Amarista C; Solà I
    Clin Adv Hematol Oncol; 2019 Apr; 17(4):234-243. PubMed ID: 31188815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of pain in pediatric sickle cell disease: understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation.
    Smith TP; Schlenz AM; Schatz JC; Maitra R; Sweitzer SM
    Blood Cells Mol Dis; 2015 Feb; 54(2):155-9. PubMed ID: 25486928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay.
    Lancelot M; White J; Sarnaik S; Hines P
    Br J Haematol; 2017 Aug; 178(3):479-481. PubMed ID: 27341635
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
    Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
    Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.